Introduction: Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine tumor. Prognostic factors currently included in the reference AJCC classification are mainly clinical.
Aim(s): Our objectives were to analyse clinicopathological prognostic factors and molecules of 3 main signaling pathways (mTOR, CXCR4 and PD1/PDL1) potentially involved in MCCs. Activity of PD1/PD-L1 inhibitors has been recently shown.
Materials and methods: In a multicenter retrospective study, we collected 136 tumor samples included in paraffin from 122 patients between 2005 and 2013. We analyzed histological characteristics on H&E-whole slides, and immunochemical characteristics on Tissue Microarrays. We collected clinical data and follow-up for 77 patients.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Basic Science - Signaling pathways, receptors, biomarkers
Presenting Author: Jonathan Benhamou
, Deschamps L
, Vergier B
, Pham-Ledard A
, Carlotti A
, Avril M F
, Ortonne N
, Zehou O
, Durlach A
, Grange F
, Couvelard A
, Maubec E
To read results and conclusion, please login ...
Further abstracts you may be interested in